← Back to Clinical Trials
Recruiting NCT03772275
Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure
Trial Parameters
Condition Heart Failure
Sponsor Sherief Abd-Elsalam
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2018-10-01
Completion 2026-10
Interventions
New york Heart Association Class II-IVNew york Heart Association Class I
Brief Summary
Clinical and Economic study of some new biomarkers in chronic heart failure.
Eligibility Criteria
Inclusion Criteria: * NYHA-Class II-IV Exclusion Criteria: * Liver or renal dysfunction. --DM
Related Trials
NCT06541509
Mechanisms of Semaglutide Therapy in Heart Failure Patients
View Trial →
NCT05596253
Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis
View Trial →
NCT07343895
Population-based Atrial Fibrillation Screening in Individuals With NT-proBNP Above Median in the Tro
View Trial →